Lauret E - Search Results

1

Structural and functional analysis of a growth-regulated gene, the human calcyclin.

Ferrari S, Calabretta B, deRiel JK, Battini R, Ghezzo F, Lauret E, Griffin C, Emanuel BS, Gurrieri F, Baserga R. Ferrari S, et al. Among authors: lauret e. J Biol Chem. 1987 Jun 15;262(17):8325-32. J Biol Chem. 1987. PMID: 3036810 Free article.

2

Growth factor regulation of the promoter for calcyclin, a growth-regulated gene.

Ghezzo F, Lauret E, Ferrari S, Baserga R. Ghezzo F, et al. Among authors: lauret e. J Biol Chem. 1988 Apr 5;263(10):4758-63. J Biol Chem. 1988. PMID: 2832406 Free article.

3

Inhibition of gene expression at the translational level by cotransfection with competitor plasmids.

Lauret E, Baserga R. Lauret E, et al. DNA. 1988 Apr;7(3):151-6. doi: 10.1089/dna.1988.7.151. DNA. 1988. PMID: 3163543

4

Role of the promoter in the regulation of the thymidine kinase gene.

Travali S, Lipson KE, Jaskulski D, Lauret E, Baserga R. Travali S, et al. Among authors: lauret e. Mol Cell Biol. 1988 Apr;8(4):1551-7. doi: 10.1128/mcb.8.4.1551-1557.1988. Mol Cell Biol. 1988. PMID: 3380089 Free PMC article.

5

Stable antiviral expression (SAVE) as an approach to somatic cell gene therapy directed against HIV infection.

De Maeyer E, Seif I, Vieillard V, Cases O, Rousseau V, De Maeyer-Guignard J, Lauret E. De Maeyer E, et al. Among authors: lauret e. Hokkaido Igaku Zasshi. 1994 Nov;69(6):1288-93. Hokkaido Igaku Zasshi. 1994. PMID: 7705744 Review.

6

Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.

Vieillard V, Lauret E, Rousseau V, De Maeyer E. Vieillard V, et al. Among authors: lauret e. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2689-93. doi: 10.1073/pnas.91.7.2689. Proc Natl Acad Sci U S A. 1994. PMID: 7511818 Free PMC article.

7

Exploring interferon beta for gene therapy of HIV infection.

Lauret E, Vieillard V, Rousseau V, De Maeyer-Guignard J, De Maeyer E. Lauret E, et al. Res Immunol. 1994 Oct-Dec;145(8-9):674-7; discussion 677-8. doi: 10.1016/s0923-2494(05)80053-7. Res Immunol. 1994. PMID: 7754218 Review. No abstract available.

8

Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.

Lauret E, Riviere I, Rousseau V, Vieillard V, De Maeyer-Guignard J, De Maeyer E. Lauret E, et al. Hum Gene Ther. 1993 Oct;4(5):567-77. doi: 10.1089/hum.1993.4.5-567. Hum Gene Ther. 1993. PMID: 8280795

9

Antiviral activity of autocrine interferon-beta requires the presence of a functional interferon type I receptor.

Rousseau V, Cremer I, Lauret E, Rivière I, Aguet M, De Maeyer E. Rousseau V, et al. Among authors: lauret e. J Interferon Cytokine Res. 1995 Sep;15(9):785-9. doi: 10.1089/jir.1995.15.785. J Interferon Cytokine Res. 1995. PMID: 8536106

10

Autocrine interferon-beta synthesis for gene therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healthy and HIV-infected individuals.

Vieillard V, Lauret E, Maguer V, Jacomet C, Rozenbaum W, Gazzolo L, De Maeyer E. Vieillard V, et al. Among authors: lauret e. AIDS. 1995 Nov;9(11):1221-8. AIDS. 1995. PMID: 8561974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters